The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients

American Journal of Chinese Medicine

Volumn 34, Issue 6, 2006, Pages 927-935

  Hsu, Chung Hua ^a,d   Hwang, Kung Chang ^a   Chao, Chung Liang ^b   Chang, Steve G N ^a   Ker, Cheng Chin ^a   Chien, Lin Chen ^a   Ho, Mei Shang ^c   Lin, Jaung Geng ^e   Chen, Yi Ming ^d   Chou, Pesus ^d  

^a TAIPEI HOSPITAL   (Taiwan)

^b Kinmen Hospital   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Avian Influenza; Chinese Medicine; Herbal Medicine; SARS

Indexed keywords

AGARICUS BLAZEI EXTRACT; AGASTACHE RUGOSA EXTRACT; BUPLEURUM CHINENSE EXTRACT; CHINESE DRUG; CLARITHROMYCIN; CORDYCEPS SINENSIS EXTRACT; GARDENIA JASMINOIDES EXTRACT; GINSENG EXTRACT; GYPSUM FIBROSUM EXTRACT; HERBACEOUS AGENT; IMMUNOGLOBULIN G; METHYLPREDNISOLONE SODIUM SUCCINATE; NOTOPTERYGIUM INCISIUM EXTRACT; OPHIOPOGON JAPONICUS EXTRACT; PAEONIA LACTIFLORA EXTRACT; PINELLIA TERNATA EXTRACT; PLACEBO; PLATYCODON GRANDIFLORUM EXTRACT; PORIA COCOS EXTRACT; RIBAVIRIN; ROBATROL; SCHIZONEPETA TENUIFOLIA EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SILER DIVARICATUM EXTRACT;

ADULT; AGARICUS BRAZEI; AGASTACHE; AGASTACHE RUGOSA; ARTICLE; AVIAN INFLUENZA; BUPLEURUM CHINENSE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ELIXIR; FATALITY; FEMALE; GYPSUM FIBROSUM; HERBAL MEDICINE; HUMAN; LOADING DRUG DOSE; MALE; NOTOPTERYGIUM INCISIUM; OPHIOPOGON JAPONICUS; PINELLIA; PINELLIA TERNATA; SCHIZONEPETA TENUIFOLIA; SEVERE ACUTE RESPIRATORY SYNDROME; SILER DIVARICATUM; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT INDICATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CLARITHROMYCIN; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUNG; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RIBAVIRIN; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TAIWAN;

EID: 33845515119     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06004405     Document Type: Article

References (24)

1. Avendano, M., P. Derkach and S. Swan. Clinical course and management in health care workers in Toronto: A case series. CMAJ 169: 1649-1660, 2003.
2. Beigel, J.H., J. Farrar, A.M. Han, F.H. Hayden, R. Hyer, M.D. de Jong, S. Lochindarat, T.K. Nguyen, T.H. Nguyen, T.H. Tran, A. Nicoll, S. Touch, K.Y. Yuen and Writing Committee of the World Health Organization (WHO) Consultation on Human Influenze A/H5. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353: 1374-1385, 2005.
3. Booth, C.M., L.M. Matukas, G.A. Tomlinson, A.R. Rachlis, H.A. Dwosh, S.L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I.E. Ephtimios, I. Kitai, B.D. Mederski, S.B. Shadowitz, W.L. Gold, L.A. Hawryluck, E. Rea, J.S. Chenkin, D.W. Cescon, S.M. Poutanen and A.S. Detsky. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289: 1-9, 2003.
4. CDC. Updated interim surveillance case definition for severe respiratory syndrome (SARS) - United States, June 11, 2003. JAMA 290: 34, 2003.
5. Chan, J.W., C.K. Ng, Y.H. Chan, T.Y. Mok, S. Lee, S.Y. Chu, W.L. Law, M.P. Lee and P.C. Li. Short-term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 58: 686-689, 2003.
6. Chen, L., Shao H.J. and Y.B. Su. Coimmunization of Agaricus brazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune response. Int. Immunopharm. 4: 403-409, 2004.
7. De Jong, M.D., V.C. Bach, T.Q. Phan, M.H. Vo, T.T. Tran, B.H. Nguyen, M. Beld, T.P. Le, H.K. Truong V.V. Nguyen, T.H. Tran, Q.H. Do and J. Farrar. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352: 686-691, 2005.
8. Drosten, C., S. Gunther, W. Preiser, S. Van der Werf, H.R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R.A.M. Fouchier, A. Berger, A.M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J.C. Manuguerra, S. Muller, V. Rickert, M. Sturmer, S. Vieth, H.D. Klenk, A.D.M.E. Osterhaus, H. Schmitz and H.W. Doerr. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348: 1967-1976, 2003.
9. Ho, W. Guidelines on management of severe acute respiratory syndrome (SARS). Lancet 361: 1313-1315, 2003.
10. Jia, W. and W. Gao. Is traditional Chinese medicine useful in the treatment of SARS? Phytother. Res. 17: 840-841, 2003.
11. Ksiazek, T.G., D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, L.J. Anderson and SARS Working Group. A novel coronavirus association with severe acute respiratory syndrome. N. Engl. J. Med. 348: 1953-1966, 2003.
12. Le, Q.M., M. Kiso, K. Someya, Y.T. Sakai, T.H. Nguyen, K.H. Nguyen, N.D. Pham, H.H. Ngyen, S. Yamada, Y. Muramoto, T. Horimoto, A. Takada, H. Goto, T. Suzuki, Y. Suzuki and Y. Kawaoka. Isolation of drug-resistant H5N1 virus. Nature 438: 754, 2005.
13. Li, G., X. Chen and A. Xu. Profile of specific antibody to the SARS-associated coronavirus. N. Engl. J. Med. 349: 508-509, 2003.
14. Nakajima, A., T. Ishida, M. Koga, T. Takeuchi, O. Mazda and M. Takeuchi. Effect of hot water extract from Agaricus brazei Murill on antibody-producing cells in mice. Int. Immunopharmacol. 2: 1205-1211, 2002.
15. Peiris, J.S., S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, V.C. Cheng, K.H. Chan, D.N. Tsang, R.W. Yung, T.K. Ng, K.Y. Yuen and SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319-1325, 2003.
16. Sorimachi, K., Y. Ikehara, G. Maezato, A. Okubo, S. Yamazaki, K. Akimoto and A. Niwa. Inhibition by Agaricus brazei Murill fractions of cytopathic effect induced by western equine encephalitis virus on VERO cell in vitro. Biosci. Biotechnol. Biochem. 65: 1645-1647, 2001.
17. So, L.K., A.C. Lau, L.Y. Yam, T.M. Cheung, E. Poon, R.W. Yung and K.Y. Yuen. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 361: 1615-1617, 2003.
18. Stöhr, K. Preventing and treating influenza (neuraminidase inhibitors are clinically effective but have limitation). Br. Med. J. 326: 1235-1236, 2005.
19. Tsang, K.W., P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, M. Chan-Yeung, W.K. Lam, W.H. Seto, L.Y. Yam, T.M. Cheung, P.C. Wong, B. Lam, M.S. Ip, J. Chan, K.Y. Yuen and K.N. Lai. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348: 1977-1985, 2003.
20. Tsang, K.W.T., P. Eng, C.K. Liam, Y.S. Shim and W.K. Lam. H5N1 influenza pandemic: Contingency plans. Lancet 366: 533-534, 2005.
21. Ungchusak, K., P. Auewarahul, R. Ditphati, W. Auwanit, P. Puthavathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N.J. Cox, S.R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J.M. Simmerman and S. Chunsutthiwat. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352: 330-340, 2005.
22. World Health Organization. Update 96 - Taiwan, China SARS transmission interrupted in last outbreak area. Available at: http//www.who.int./csr/ sarscountry/2003_07_05/en/. Accessed July 15, 2003a.
23. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at: http//www.who.int./csr/sarscountry/2003_09_26/en/. Accessed September 30, 2003b.
24. Zakay-Zones, Z., N. Varsano, M. Zlotnik, O. Manor, L. Regev, M. Schlesinger and M. Mumcuglu. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J. Altern. Complement. Med. 1: 361-369, 1995.